Ralph Wedgwood

2006

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Whom Ralph Wedgwood trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Alexander Bird

Who trusts Ralph Wedgwood overall

  1. Conor McHugh

Papers from Ralph Wedgwood's perspective

Ordered by how strongly the researchers Ralph Wedgwood trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Counterfactuals
  2. Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib (Clinical Cancer Research)
  3. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
  4. Mutations of the BRAF gene in human cancer (Nature)
  5. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma (New England Journal of Medicine)
  6. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib (PLoS Medicine)
  7. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer (Nature)
  8. BRAF and RAS mutations in human lung cancer and melanoma. (Cancer Research)
  9. RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF (Nature)
  10. Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis (British Journal of Cancer)

Their papers